Seven Anchorage patients develop rare heart infection from gonorrhea

The Alaska Section of Epidemiology reported seven cases of gonococcal endocarditis in Anchorage between December 2024 and March 2026. The infection occurs when gonorrhea bacteria spread to heart valves. The condition is rare and life threatening. The findings appeared May 19, 2026, in a bulletin titled "Increase in Gonococcal Endocarditis Cases — Alaska, 2024–2026."

The seven cases occurred among 30 patients diagnosed with disseminated gonococcal infection during the 16-month period. All seven patients developed sepsis. Many experienced septic shock or respiratory failure. Most required prolonged hospitalization and invasive cardiac procedures. One patient died.

The cases were associated with homelessness, methamphetamine use, fentanyl use, and injection drug use, the bulletin stated. The findings suggest risk factors at the intersection of the sexually transmitted infection epidemic with substance use and housing crises.

Several patients lacked typical genital symptoms. That made diagnosis difficult. The bulletin emphasized the need for clinicians to consider disseminated gonococcal infection and endocarditis in patients presenting with unexplained systemic illness or new cardiac findings. Disseminated gonococcal infection occurs when gonorrhea bacteria spread through the bloodstream. Endocarditis develops when the bacteria infect the inner lining of the heart chambers and valves.

The bulletin called for early recognition of the condition. It recommended diagnostic testing from mucosal and disseminated sites. It urged prompt treatment with intravenous ceftriaxone. It also recommended cardiac evaluation when indicated, partner notification, and timely public health reporting.

Health officials asked clinicians and public health workers to help spread awareness of the cluster and the diagnostic challenges it presents.